Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 3, 2023Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
8-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange ActMar 10, 2023Open Registration of certain classes of securities 12(g) of the Securities Exchange Act in HTML.Open Registration of certain classes of securities 12(g) of the Securities Exchange Act in DOC file.Open Registration of certain classes of securities 12(g) of the Securities Exchange Act in PDF file.Open Registration of certain classes of securities 12(g) of the Securities Exchange Act in XLS file.